Like father like son: how brain health can traverse generations

Your father's exercise routine may have made you smarter according to EU-funded researchers studying how lifestyle choices affect brain function and memory. The findings could lead to new treatments for neurodegenerative conditions such as Alzheimer's disease.

Countries
Countries
  Algeria
  Argentina
  Australia
  Austria
  Bangladesh
  Belarus
  Belgium
  Benin
  Bolivia
  Bosnia and Herzegovina
  Brazil
  Bulgaria
  Burkina Faso
  Cambodia
  Cameroon
  Canada
  Cape Verde
  Chile
  China
  Colombia
  Costa Rica
  Croatia
  Cyprus
  Czechia
  Denmark
  Ecuador
  Egypt
  Estonia
  Ethiopia
  Faroe Islands
  Finland
  France
  French Polynesia
  Georgia

Countries
Countries
  Algeria
  Argentina
  Australia
  Austria
  Bangladesh
  Belarus
  Belgium
  Benin
  Bolivia
  Bosnia and Herzegovina
  Brazil
  Bulgaria
  Burkina Faso
  Cambodia
  Cameroon
  Canada
  Cape Verde
  Chile
  China
  Colombia
  Costa Rica
  Croatia
  Cyprus
  Czechia
  Denmark
  Ecuador
  Egypt
  Estonia
  Ethiopia
  Faroe Islands
  Finland
  France
  French Polynesia
  Georgia


  Infocentre

Published: 5 January 2021  
Related theme(s) and subtheme(s)
Frontier research (ERC)
Health & life sciencesGenetic engineering  |  Genomics  |  Health & ageing  |  Health & special needs  |  Major diseases  |  Medical research  |  Neuroscience
Research policyHorizon 2020
Science in societyFuture science & technology
Countries involved in the project described in the article
Germany
Add to PDF "basket"

Like father like son: how brain health can traverse generations

Image

Photo by Tim Mossholder from StockSnap

The groundbreaking research in the DEPICODE project, supported by the European Research Council, is deepening our understanding of epigenetics: how external influences such as physical activity, mental stimulation, diet and stress influence how our cells read genetic information. While it is widely recognised that exercise is good for our brains –strengthening neural connections to sharpen thinking and enhance memory – the DEPICODE team’s findings suggest some of these benefits can even be passed on to our children.

This research has important implications not only for prospective parents but also for the identification of biological signatures, or biomarkers, of epigenetic changes that can forewarn of disease, and for the development of new treatments. ‘We have gained a better understanding of the epigenetic processes that control cognitive function,’ says DEPICODE principal investigator André Fischer at the German Center for Neurodegenerative Diseases in Göttingen.

‘Our data will help to develop therapeutic strategies to treat cognitive diseases in two ways: first, by identifying novel drug targets, and secondly, by providing evidence that epigenetic markers could serve as suitable biomarkers to assess disease risk and initiate preventive therapies,’ he continues.

The team’s work has already led to one ongoing phase 2a clinical trial in Germany to assess whether Vorinostat, a cancer drug that affects gene expression, could also be a safe and effective treatment for patients with mild Alzheimer’s disease.

‘The DEPICODE project is embedded within our overall research approach to find epigenetic therapies and biomarkers for neurodegenerative diseases such as Alzheimer’s, the most common form of dementia, which causes an enormous social and economic burden worldwide,’ Fischer says.

Brain-boosting microRNAs

In this context, circulating microRNAs are of particular importance. These tiny molecules circulate in the blood and are known to influence the inner workings of genes. A cluster of them, known as miRNAs 212/132, are linked to brain development and memory, and hence could serve as potential biomarkers of cognitive disease.

In laboratory studies with mice, levels of miRNAs 212/132 have been found to increase in the hippocampus region of the brain after exercise, potentially strengthening neural connections between brain cells involved in memory and learning. Energetic mice with higher miRNAs 212/132 levels tend to perform better on cognitive tests than their sedentary counterparts – and, it turns out, so too do their offspring.

The DEPICODE researchers found that these microRNAs are also present in sperm as well as blood, and can transmit epigenetic benefits to a father’s offspring even if the mothers are sedentary and even if the pups never get on a running wheel.

‘We analysed exercise as a protective mechanism in cognitive disease and could show for the first time that exercising parents transmit a cognitive benefit to the next generation. This is mediated via epigenetic processes, namely altered microRNA expression in sperm, which produce the beneficial transgenerational effect,’ Fischer says.

To date, the research has been conducted with mice, but it is possible that the same effects occur in humans – a theory that is set to be explored further by Fischer and his team.

While the discovery might encourage prospective fathers to visit the gym, the broader findings about the role of microRNAs and the new insights gained in DEPICODE into epigenetic processes could lead to novel therapies for a range of neurological conditions, potentially benefiting millions of people worldwide.

Project details

  • Project acronym: DEPICODE
  • Participants: Germany (coordinator)
  • Project N°: 648898
  • Total costs: EUR 1 729 125
  • EU contribution: EUR 1 729 125
  • Duration: September 2015 to August 2021

See also

 

Convert article(s) to PDF

No article selected




loading
Print Version
Share this article
See also
More information about project DEPICODE